The findings, that RDM1 was over-expressed in lung adenocarcinoma and that high RDM1 was strongly associated with poor clinical outcomes, suggesting the oncogenic role of RDM1 in human lung adenocarcinomas. This evidence concerns the gene RDM1 and lung adenocarcinoma.